{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:44:21Z","timestamp":1790905461730,"version":"4.1.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"abstract":"<jats:p>Activation of the mineralocorticoid receptor (MR) in the context of a high salt intake produces cardiovascular inflammation plus cardiac fibrosis and failure. Inactivation of vascular 11\u03b2-hydroxysteroid dehydrogenase type 2 activity in intact animals by carbenoxolone (CBX) produces a similar pathology, presumably reflecting coronary vascular MR activation by endogenous glucocorticoids. To test this hypothesis, we have used adrenalectomized rats, without endogenous corticosteroids, and examined the consequences of corticosterone (CORT) replacement on a series of cardiovascular disease parameters. Uninephrectomized adrenalectomized Sprague Dawley rats given 1% NaCl\/0.3% KCl to drink were treated for 8 d as follows: control; 20 mg deoxycorticosterone (DOC); 2 mg\/d CORT; 2.5 mg\/d CBX; CORT plus CBX (CORT\/CBX); and CORT\/CBX plus 100 mg\/kg\u00b7d eplerenone. Markers of cardiac oxidative stress (p22phox and NOX4 mRNA) were up-regulated in the DOC and CORT\/CBX groups; in contrast, inflammatory cell infiltration was increased and endothelial nitric oxide synthase down-regulated by CORT as well as by DOC and CORT\/CBX. In the kidney, connective tissue growth factor mRNA levels were increased by DOC and CORT\/CBX; in contrast, DOC had no effect on mRNA levels for channel inducing factor or endothelin 3, which were elevated only by CORT\/CBX. All changes noted were reversed by eplerenone. Rats given 10-fold lower CORT (0.2 mg\/d) with or without CBX showed no change in any parameter. These results suggest that there exist distinct but overlapping ligand-specific MR-mediated tissue responses to a classic mineralocorticoid (DOC) and to the glucocorticoid CORT, in the presence and absence of CBX to block vascular 11\u03b2-hydroxysteroid dehydrogenase type 2.<\/jats:p>","DOI":"10.1210\/en.2009-1476","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T01:39:59Z","timestamp":1271900399000},"page":"2622-2628","source":"Crossref","is-referenced-by-count":29,"title":["Activation of Mineralocorticoid Receptors by Exogenous Glucocorticoids and the Development of Cardiovascular Inflammatory Responses in Adrenalectomized Rats"],"prefix":"10.1210","volume":"151","author":[{"given":"Morag J.","family":"Young","sequence":"first","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Morgan","sequence":"first","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Brolin","sequence":"first","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Fuller","sequence":"first","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Funder","sequence":"first","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2010,4,21]]},"reference":[{"key":"2020071612423610000_R1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1073\/pnas.0503878102","article-title":"Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity.","volume":"103","author":"Berger","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612423610000_R2","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"2020071612423610000_R3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure.","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"2020071612423610000_R4","first-page":"E388","article-title":"Characterization of aldosterone binding sites in circulating human mononuclear leukocytes","volume":"248","author":"Armanini","year":"1985","journal-title":"Am J Physiol"},{"key":"2020071612423610000_R5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.0000088855.06598.5B","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids.","volume":"42","author":"Christy","year":"2003","journal-title":"Hypertension"},{"key":"2020071612423610000_R6","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/00004872-198812040-00038","article-title":"Steroid binding to cardiac type I receptors: in vivo studies","volume":"6","author":"Pearce","year":"1988","journal-title":"J Hypertens Suppl"},{"key":"2020071612423610000_R7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.35.5.1099","article-title":"Role of 11\u03b2-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries.","volume":"35","author":"Alzamora","year":"2000","journal-title":"Hypertension"},{"key":"2020071612423610000_R8","first-page":"E601","article-title":"Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies","volume":"270","author":"Myles","year":"1996","journal-title":"Am J Physiol"},{"key":"2020071612423610000_R9","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress.","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"2020071612423610000_R10","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071612423610000_R11","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis.","volume":"93","author":"Young","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071612423610000_R12","first-page":"E657","article-title":"Determinants of cardiac fibrosis in experimental hypermineralocorticoid states","volume":"269","author":"Young","year":"1995","journal-title":"Am J Physiol"},{"key":"2020071612423610000_R13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1042\/CS20080247","article-title":"Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart.","volume":"116","author":"Wilson","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"2020071612423610000_R14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2006.09.039","article-title":"Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension.","volume":"552","author":"Fujii","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"2020071612423610000_R15","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.HYP.0000192651.06674.3f","article-title":"Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.","volume":"46","author":"Sun","year":"2005","journal-title":"Hypertension"},{"key":"2020071612423610000_R16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Eng J Med"},{"key":"2020071612423610000_R17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"key":"2020071612423610000_R18","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1210\/en.2007-0209","article-title":"Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid\/salt administration?","volume":"148","author":"Rickard","year":"2007","journal-title":"Endocrinology"},{"key":"2020071612423610000_R19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/en.2002-220926","article-title":"Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11\u03b2-hydroxysteroid dehydrogenase inactivation.","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"2020071612423610000_R20","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1210\/en.2006-0658","article-title":"The role of the glucocorticoid receptor in mineralocorticoid\/salt mediated cardiac fibrosis.","volume":"147","author":"Rickard","year":"2006","journal-title":"Endocrinology"},{"key":"2020071612423610000_R21","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"2020071612423610000_R22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jacc.2005.09.051","article-title":"Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.","volume":"47","author":"Grieve","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2020071612423610000_R23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.RES.0000099504.30207.F5","article-title":"Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy.","volume":"93","author":"Byrne","year":"2003","journal-title":"Circ Res"},{"key":"2020071612423610000_R24","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/HYPERTENSIONAHA.107.105718","article-title":"Glucocorticoid-related signaling effects in vascular smooth muscle cells.","volume":"51","author":"Molnar","year":"2008","journal-title":"Hypertension"},{"key":"2020071612423610000_R25","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/en.2006-0965","article-title":"A direct effect of aldosterone on endothelin-1 gene expression in vivo.","volume":"148","author":"Wong","year":"2007","journal-title":"Endocrinology"},{"key":"2020071612423610000_R26","first-page":"105","article-title":"Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats.","volume":"45","author":"Januszewicz","year":"1994","journal-title":"J Physiol Pharmacol"},{"key":"2020071612423610000_R27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1210\/endo.140.3.6582","article-title":"Acute regulation by corticosteroids of channel-inducing factor gene messenger ribonucleic acid in the distal colon.","volume":"140","author":"Brennan","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612423610000_R28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2008.12.008","article-title":"Glucocorticoid receptor plays an indispensable role in mineralocorticoid receptor-dependent transcription in GR-deficient BE(2)C and T84 cells in vitro.","volume":"302","author":"Tsugita","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612423610000_R29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0896-6273(94)90431-6","article-title":"Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS.","volume":"13","author":"Trapp","year":"1994","journal-title":"Neuron"},{"key":"2020071612423610000_R30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/MCB.21.3.781-793.2001","article-title":"Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces.","volume":"21","author":"Savory","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2020071612423610000_R31","first-page":"170","article-title":"Novel early aldosterone\/salt regulated genes in mineralocorticoid receptor-mediated cardiovascular response.","volume":"52","author":"Lam","year":"2008","journal-title":"Hypertension"},{"key":"2020071612423610000_R32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ncb1922","article-title":"Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription.","volume":"11","author":"Stavreva","year":"2009","journal-title":"Nat Cell Biol"},{"key":"2020071612423610000_R33","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ncb0909-1051","article-title":"Steroid hormone pulsing drives cyclic gene expression.","volume":"11","author":"Desvergne","year":"2009","journal-title":"Nat Cell Biol"},{"key":"2020071612423610000_R34","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1172\/JCI104436","article-title":"Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro.","volume":"40","author":"Crabbe","year":"1961","journal-title":"J Clin Invest"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/6\/2622\/9010718\/endo2622.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/6\/2622\/9010718\/endo2622.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T21:37:11Z","timestamp":1594935431000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/151\/6\/2622\/2456812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,21]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2009-1476","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,21]]}}}